Pfizer Vaccine For Kids May Not Be Approved Until November

The Wall Street Journal reports that Pfizer's application for FDA approval of a low-dose COVID-19 vaccine for children aged 5 to 11 is delayed. Originally aiming for approval by October, Pfizer submitted its data recently, but the full application may not be completed until mid-October. Consequently, the FDA's decision might be postponed until closer to Thanksgiving.

What new insight or understanding did you gain from this video?